Barr Eliav 4

What Happened Barr Eliav, a member of Veracyte's board of directors, was awarded 5,272 restricted stock units (RSUs) on June 11, 2026. The Form 4 reports these as an award/acquisition at $0.00 per share (no cash paid at grant). This is a compensation award, not an open-market purchase or sale.

Key Details

• Transaction date: June 11, 2026; filing date (Form 4): June 15, 2026.
• Grant size and price: 5,272 RSUs at $0.00 per share (award).
• Shares owned after the transaction: not specified in the information provided in this summary.
• Vesting: RSUs vest in full on the first anniversary of the grant or immediately prior to the company's next annual meeting of stockholders, if earlier; they also vest in full upon a change in control of the company (per footnote).
• Transaction type: Code A (award/grant). No tax-withholding or sale reported in this filing.

Context RSUs are a form of equity compensation that convert into shares if and when they vest; they do not represent an immediate cash transaction or an open-market trade. Director awards are common and generally reflect compensation practices rather than a direct signal of the director’s short-term view on the stock. The grant includes typical vesting protections, including accelerated vesting on a change in control.